Real photonics company. Pre-meaningful-revenue. Story-stock valuation. POET has the Optical Interposer™ (silicon photonics platform integrating lasers + photonics + electronics on a single substrate) and won ECOC 2025 "Most Innovative" award. They demoed 200G/lane and 1.6T optical engines at OFC 2026. But: Wolfpack Research short report alleges only ~$2.3M total revenue since 2020 against ~$818M market cap (P/S ratio ~760x — basis note 2026-08-03: the ~760x reconciles against FY2025's single-year ~$1.07M revenue, not the cumulative ~$2.3M this sentence quotes; both figures are real, on different windows). That's not a stock you size like a fundamental conviction — it's a thesis-trade with binary outcomes around customer announcements / design-win disclosures.

Quick Snapshot

Price Table (last 5 sessions, 1d intervals)

Period: 2026-03-30 → 2026-04-28 · 21 entries · current $8.03

• High: $15.50 (parabolic top)
• Low: $4.87 (during pullback)
• Open: $5.23
• Day change: +1.01%

Action Matrix

What POET Actually Does

Product: the Optical Interposer™ — a wafer-scale platform that integrates III-V laser chips, silicon photonic waveguides, and electronic dies into a single integrated package. The pitch: replace discrete pluggable optical modules with chip-scale optical engines that go into hyperscaler switches and AI accelerators.

Why it matters: the AI datacenter is a bandwidth bottleneck. Co-packaged optics (CPO) and on-package optics are the next-gen solution. POET's interposer is one approach (alongside competing approaches from Intel, Broadcom, Cisco, Lumentum, MACOM, etc.). At 1.6Tbps per engine, POET is in the same conversation as the leaders.

Status: "commercialization underway" per their March 2026 announcement. Demoed publicly at OFC 2026 (the Optical Fiber Communications conference — the major industry event). Won ECOC 2025 "Most Innovative" award. So real product, real demonstrations.

The catch: revenue is tiny. Wolfpack's claim of ~$2.3M total since 2020 is consistent with a company that's been demoing for years but hasn't hit volume production. The leading-indicators tool shows +1075% YoY revenue growth — but off a near-zero base (the tool's rate isn't reproducible from the annual filings, which compute ~+2,495% FY2025-over-FY2024; either way the dollar base is ~$1M). So small absolute numbers, large percentage growth.

Where POET Fits in the Optical Supercycle Thesis

Tonight's optical-supply-chain scan validated the supercycle. AXTI +319% 3M, AAOI +247%, LWLG +227%, AEHR +207%, LITE +107% — and yet AXTI/AAOI RSI sits at 53, LITE at 48. Real supply constraint. Every reporting ticker in the optical cohort is strong-up or up.

POET fits at the smallest, highest-beta end of this trade. Compared to peers:

Read: POET and LWLG are in the same speculative bucket — pre-revenue or early-revenue companies with real technology and binary outcomes around customer announcements. They move together on optical sentiment but reflect bets on adoption, not earnings.

What's Driving the +58% 30D Move

Likely catalysts (chronological):

• OFC 2026 (March) — POET demoed advanced optical engines. The "show your wares to hyperscalers" event.
• Reddit intake mentions (2026-04-28, 2 posts) — retail attention surfacing. Could be coordinated, could be organic.
• Industry tailwind — entire optical supercycle ripping (LWLG +75% 30D, AXTI +30%, AAOI +61%). POET as small-cap leveraged play on the same theme.

The -22.89% 7D pullback is consistent with profit-taking after a +60% rip OR the Wolfpack short report cycling through. Could be either; matters less than the new range ($6-15) which is now established.

Risks

1. Valuation. P/S ~760x means the entire stock price is forward-discounted commercialization. Any timing slip on volume production is binary downside.
2. Wolfpack short report. Active short campaign citing minimal revenue, alleged "stock promote" history, business-model pivots. Whether or not the allegations are correct, the report itself creates pressure on the tape.
3. PFIC status. POET is Canadian-domiciled; the Passive Foreign Investment Company tax treatment is unfavorable for US holders. They've announced plans to redomicile to the US. Until that closes, complex tax situation.
4. Customer concentration risk. If POET's first big production order is from a single hyperscaler, qualifying delays compound. They haven't disclosed customer names publicly (typical pre-volume).
5. Competing photonics approaches. Co-packaged optics is a battle between several incumbents (Intel, Broadcom, Cisco, NVIDIA's own efforts). POET could win, lose, or get acquired — but not all three.

Catalysts

What would move POET materially:

• Customer announcement — any named hyperscaler buying optical engines in volume. Single biggest catalyst.
• Volume production milestone — first ramp report ($10M+ quarter, not $1M).
• OFC 2027 demo (March 2027) — annual rhythm; "did they keep their lead?"
• Acquisition rumor — POET as target for Intel, Cisco, or MACOM if they need POET's IP for their own roadmap.
• Redomiciling completion — removes PFIC overhang, broadens US institutional ownership.
• Short-seller resolution — Wolfpack's allegations either get proven (POET tanks) or quietly recede (POET de-stigmatizes).

Position Sizing

This is NOT a core position. Suggested approach:

• Starter: $500-1,000 in yolo strategy (small dollar-amount, high-volatility tolerance). Treat as 100% loss tolerance.
• Don't add to: bench-signals (quality), claude-trader, claude-momentum, dca-larry — POET doesn't fit those mandates.
• Stop: $6 (recent low support; below this is failed thesis territory).
• First target: $12-15 (recent high range). Trim half.
• Long target: $25-30 (would require an actual customer disclosure or volume revenue print). Hold the rest.

Don't size on conviction. Size on tolerance for binary outcome.

How POET Connects to Other Theses

Optical-supercycle (PRIMARY): confirmed direct hit. Same physics-down thesis as LWLG/AXTI/COHR/LITE/AAOI. POET is the smallest, highest-beta exposure to it.

AI-power-bottleneck: indirect — co-packaged optics reduces datacenter power per bit. POET's product roadmap includes claims of significant power-per-bit improvements at the rack level.

Cross-thesis convergence database: POET is NOT in any current trace. COHR (4 traces), LIN (3), APD (3) are the convergence picks. POET is a one-source-only signal so far.

What to Watch Next 30 Days

Recommendation

Add to optical-supply-chain watchlist ✓ (done 2026-04-28). Do NOT add to focus list. Consider $500 starter via yolo if RSI cools below 40, contingent on:

1. No new Wolfpack short-report developments
2. Optical-supercycle peers (LITE/AXTI/AAOI) holding strong-up
3. POET maintains >$5 support

This deep-dive should be re-run after the next earnings print (expected May/June 2026). The story changes if revenue prints meaningfully above $5M for the quarter (validates commercialization claim) or below $1M (validates Wolfpack's "stock promote" framing).

Sources

• POET Technologies official news: https://www.poet-technologies.com/news/
• ECOC 2025 award announcement: https://www.poet-technologies.com/news/poet-technologies-wins-most-innovative-award-at-ecoc-2025
• OFC 2026 demo: https://www.poet-technologies.com/news/poet-to-demonstrate-extraordinary-hybrid-laser-and-next-generation-high-powered-light-sources-for-ai-applications-at-ofc-conference
• Yahoo Finance summary: https://finance.yahoo.com/quote/POET
• Wolfpack Research short report context (Kavout summary): https://www.kavout.com/market-lens/what-triggered-poet-technologies-recent-volatility
• PFIC clarification: https://www.poet-technologies.com/news/poet-technologies-provides-clarity-on-its-passive-foreign-investment-company-pfic-status

Captured Reddit mentions (2026-04-28 intake)

• 2 posts surfaced via r/valueinvesting + r/stocks. This is the first time POET appeared in our intake firehose.
• Fundamentals figures: company-reported results (quarterly/annual filings) as available at the artifact date; predates the desk's EDGAR reconciliation gate — figures not re-verified after publication.